Ventyx Biosciences Reports Shareholder Vote Matters
| Field | Detail |
|---|---|
| Company | Ventyx Biosciences, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
Related Tickers: VTYX
TL;DR
Ventyx held a shareholder vote on June 4th. Details filed 8-K.
AI Summary
Ventyx Biosciences, Inc. filed an 8-K on June 10, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 4, 2025. The filing details corporate governance and shareholder voting matters for the company, incorporated in Delaware.
Why It Matters
This filing indicates that Ventyx Biosciences is engaging in formal shareholder voting processes, which is a standard but important part of corporate governance and decision-making.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder voting matters and does not present new financial or operational risks.
Key Numbers
- 001-40928 — Commission File Number (Identifier for Ventyx Biosciences' SEC filings)
- 83-2996852 — IRS Employer Identification No. (Tax identification number for Ventyx Biosciences)
Key Players & Entities
- Ventyx Biosciences, Inc. (company) — Registrant
- June 04, 2025 (date) — Date of earliest event reported
- June 10, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- San Diego, California (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of security holders on June 4, 2025?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text excerpt.
When was the 8-K form filed with the SEC?
The 8-K form was filed on June 10, 2025.
What is the principal executive office address for Ventyx Biosciences, Inc.?
The principal executive offices are located at 12790 El Camino Real, Suite 200, San Diego, California, 92130.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Ventyx Biosciences, Inc.'s fiscal year end?
Ventyx Biosciences, Inc.'s fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Ventyx Biosciences, Inc..